Rel-Hydroxy Itraconazole

• Description:

  Rel-Hydroxy Itraconazole (rel-R-63373) is a relative stereoisomer of Hydroxy Itraconazole. Hydroxy Itraconazole is the major active metabolite of the antifungal compound Itraconazole (HY-17514) [1].

• Product Name Alternative:

  Rel-R-63373

• UNSPSC:

  12352005

• Target:

  Drug Isomer

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Smiles:

  O=C (N (N=C1) C (C) C (O) C) N1C (C=C2) =CC=C2N (CC3) CCN3C (C=C4) =CC=C4OC[C@@H] (CO5) O[C@]5 (C6=C (C=C (C=C6) Cl) Cl) CN7C=NC=N7

• Molecular Formula:

  C35H38Cl2N8O5

• Molecular Weight:

  721.63

• References & Citations:

  [1]Breadmore MC, et al. Determination of itraconazole and hydroxyitraconazole in human serum and plasma by micellar electrokinetic chromatography. J Chromatogr A. 2003 Oct 3;1014 (1-2) :57-70.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  207970-87-4